Wetan supports startups leaders or project leaders who need to finance their project successfully. The compant helps them build a... View Article
Author Archives for Adeline Chauvigné
New member | Wetan
4 November 2025Wetan supports startups leaders or project leaders who need to finance their project successfully. The compant helps them build a... View Article
New member | LaFleur by DelleD
While the experimentation of the medical use of cannabis framed by the National Agency for Medicines began in France on... View Article
New member | LaFleur by DelleD
4 November 2025While the experimentation of the medical use of cannabis framed by the National Agency for Medicines began in France on... View Article
Update on XENOTHERA’s news
In March, XENOTHERA went on digging its wake to analyze the clinical efficacy of XAV-19. Marchwas the month for the... View Article
Update on XENOTHERA’s news
4 November 2025In March, XENOTHERA went on digging its wake to analyze the clinical efficacy of XAV-19. Marchwas the month for the... View Article
New member | Bioprox Healthcare
BIOPROX HEALTHCARE produces probiotics of bacterial origin belonging to about thirty different species mainly Lactobacillus (former genus name) and Bifidobacterium isolated from human... View Article
New member | Bioprox Healthcare
4 November 2025BIOPROX HEALTHCARE produces probiotics of bacterial origin belonging to about thirty different species mainly Lactobacillus (former genus name) and Bifidobacterium isolated from human... View Article
New member | Genourob
Genourob design, produce and commercialize medical devices for helping ACL tears diagnosis and for rehabilitation and fitness. Genourob has become the world... View Article
New member | Genourob
4 November 2025Genourob design, produce and commercialize medical devices for helping ACL tears diagnosis and for rehabilitation and fitness. Genourob has become the world... View Article
Valneva reports positive phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate
VLA2001 was well tolerated with no safety concerns identified In the high dose group : IgG seroconversion rate of 100%... View Article
Valneva reports positive phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate
4 November 2025VLA2001 was well tolerated with no safety concerns identified In the high dose group : IgG seroconversion rate of 100%... View Article
OSE Immunotherapeutics receives authorization for phase 1 clinical trial of its multi-target multi-variant COVID-19 vaccine
CoVepiT is a SARS-COV-2 vaccine activating T cell defenses through CD8 T-cell multiepitope* responses. CoVepiT epitopes are selected from 11... View Article
OSE Immunotherapeutics receives authorization for phase 1 clinical trial of its multi-target multi-variant COVID-19 vaccine
4 November 2025CoVepiT is a SARS-COV-2 vaccine activating T cell defenses through CD8 T-cell multiepitope* responses. CoVepiT epitopes are selected from 11... View Article
Immunotherapeutics in the fight against liver cancer: a world first for Rennes University Hospital and the Eugène Marquis Centre
With over 10,000 new cases every year, liver cancer is one of the most difficult cancers to treat. In Rennes,... View Article
Immunotherapeutics in the fight against liver cancer: a world first for Rennes University Hospital and the Eugène Marquis Centre
4 November 2025With over 10,000 new cases every year, liver cancer is one of the most difficult cancers to treat. In Rennes,... View Article
France Relance | Achievements in the Grand Ouest region
Source: Press release – France Relance This year, the COVID-19 health crisis has done much to reinforce the conviction that... View Article
France Relance | Achievements in the Grand Ouest region
4 November 2025Source: Press release – France Relance This year, the COVID-19 health crisis has done much to reinforce the conviction that... View Article
AFFILOGIC | Relocating its production capabilities
Winner of the French Resilience Call for Proposals in late 2020, Affilogic, a cluster member specialising in the discovery and... View Article
AFFILOGIC | Relocating its production capabilities
4 November 2025Winner of the French Resilience Call for Proposals in late 2020, Affilogic, a cluster member specialising in the discovery and... View Article